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great opportunity for advising and providing health educa-
tion for main risks and preparing passengers for a healthy
and safety itinerary.14th International Congress on Infectious Diseases (ICID) Abs
re - analysis of contemporary blood culture ﬁndings suggest
that most of these infections were pneumococcal, followed
by hemolytic (probably Group A) streptococcal infections,
and a minority of infections were due to Staphylococcus
aureus. Attempts were made at that time to reduce infec-
tion and mortality by killed bacterial vaccines. These trials
were poorly controlled, but an analysis restricted to the
prevention of pneumonia and mortality among inﬂuenza
patients who received these vaccines, suggests that vac-
cines against hemolytic streptococci and pneumococci, but
not Haemophilus inﬂuenzae, may have had some protec-
tion against pneumonia and death. In a randomised trial of
9 valent conjugate pneumococcal vaccine in children who
subsequently developed seasonal inﬂuenza in 1998 - 2000,
hospitalization for pneumonia was reduced by 45%. In the
current pandemic, postmortem data suggest that staphy-
lococcal infections are more common than in 1918, but
pneumococcal infections remain predominant. Where con-
jugate pneumococcal vaccination of children has led to herd
immunity, vaccine serotypes have been largely absent as a
cause of fatal pneumonias. The great majority of individuals
hospitalized with H1N1 pneumonia have received antibiotics
and it is probable that widespread availability of antibiotics
has contributed to the reduction in mortality associated with
this pandemic, by reducing bacterial superinfections in sus-
ceptible individuals.
doi:10.1016/j.ijid.2010.02.1893
Travelers to Latin America with special risks (Invited
Presentation)
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Several countries in Latin America double their tourist
arrivals in the last 10 years. The Andes Mountains are the
common denominator for most countries in South America.
Many peaks in this mountain range attract mountaineers and
trekkers which may be aware of the risks at high altitude.
Of importance are the Andean cities and tourism attractions
over 2,400 meters above sea level luring millions every year.
Signiﬁcant numbers of travelers to these destinations are
unaware of the health risks of altitude or come unprepared.
The diseases related to high altitude ascend are referred
to as high altitude illnesses (HAI). These comprise acute
mountain sickness (AMS), high altitude cerebral edema
(HACE), and high altitude pulmonary edema (HAPE). AMS
affects 20% to 50% of travelers to altitudes up to 4000
meters. HACE and HAPE are less common affecting 0.01% to
2% of travelers to similar altitudes. The risk factors can be
classiﬁed as intrinsic (not modiﬁable), which include age,
preexisting medical conditions, prior history of HAI, and
probably genetic factors. Modiﬁable risk factors include rate
of ascend, sleeping altitude, altitude attained, degree of
exertion, and medications. The hypoxic ventilatory response
is an individual risk factor that can be suppressed or stimu-
lated.
dts e183
Information is of paramount importance in prevention of
AI. Informed travelers are likely to comply with recom-
endations, recognize symptoms, and avoid complications.
gradual slow ascent, when possible, is as important for
revention. Other non-pharmacological measures are avoid-
ng exertion, dehydration, or use of respiratory suppressing
ubstances. AMS/HACE pharmacologic prevention consists of
cetazolamide or dexamethasone. Nifedipine, tadaﬁl, and
nhaled !-agonists are used for HAPE prevention.
Descent is effective to treat all HAI but is not always
ossible in remote areas or desirable for milder cases.
lternatives like rest, oxygen, medications, positive air-
ay pressure and hyperbarics devices provide support until
escent is possible or acclimatization ensues.
oi:10.1016/j.ijid.2010.02.1894
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Cruise travel has become one of the most popular ways to
isit different places and is increasing in terms of cruise pas-
engers, voyages and region destinations. Most passengers,
oyages and cruises are considered from low to medium
ealth risks. A cruise offers a wide spectrum of services and
s oriented to different customers with clearly different life
tyles risks from children, families up to elderly. Tradition-
lly, about one third of travelers are above 65 years old and
ther adults have some special conditions. However, dur-
ng last few years the number of cruises oriented to young
dults and visiting different regions and very peculiar envi-
onments such as the Amazons may increase the health risk
igniﬁcantly. Although, exposition to a mixture of people
rom different countries and diverse environments visited
end to change usual lifestyle or behaviors in terms of look-
ng for adventures and new activities during vacations. In
erms of travel health risks, the age of the cruise member is
xtremely related to the chance to suffer an event (sickness
r accident) due mainly to underlying chronic health prob-
ems. Most common health problems are associated with
ovement (sea-sickness) and gastrointestinal diseases.
Communicable diseases are easily disseminated because
lot of activities for long hours made in semi-enclosed cab-
ns and many times very crowded. And as in crowded places
nd high interactive communities, cruise passengers are not
n exemption for airborne diseases, as ﬂu infections and
ther acute respiratory illnesses. Injuries account for an
mportant number of inﬁrmary visits. Medical care aboard
s important for preventive and caring passengers and crew
or health and medical issues. Pre-travel consultation is aoi:10.1016/j.ijid.2010.02.1895
